BioCentury | Jul 22, 2019
Clinical News

July 22 Clinical Quick Takes: Positive psoriasis data for Arcutis; plus Intec and Renovo

...Pharma Ltd. (NASDAQ:NTEC) fell $2.44 (82%) to $0.55 Monday after reporting that Accordion Pill Carbidopa-Levodopa (AP-CD/LD...
...Inc. (NYSE:MRK) in the Phase III ACCORDANCE trial to treat Parkinson's disease. The company said AP-CD/LD...
...trial. Targets: ADCY6 (AC6) - Adenylate cyclase 6; PDE-4 - Phosphodiesterase-4 Sandi Wong, Staff Writer Accordion Pill Carbidopa/Levodopa, carbidopa/levodopa gr (AP-CD/LD) Ad5.hAC6...
BioCentury | Jun 29, 2019
Finance

All eyes on new modality launches, cancer and rare disease data in 3Q19

...ruxolitinib Treat steroid-refractory chronic graft-versus-host disease (GvHD) Phase III data YE19 Intec Pharma Ltd. (NASDAQ:NTEC) Accordion Pill carbidopa/levodopa...
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

Biogen’s fall in the wake of its decision to discontinue late-stage trials of Alzheimer’s therapy aducanumab is yet another reminder that large caps are in dire need of new pipeline products, and could serve as...
BioCentury | Aug 18, 2017
Financial News

Drug delivery play Intec raises $50M

...expects to report data in 2H18 from a Phase III trial of Accordion Pill Carbidopa-Levodopa (AP-CD/LD...
BioCentury | Aug 16, 2017
Financial News

Drug delivery play Intec raises $50M

...expects to report data in 2H18 from a Phase III trial of Accordion Pill Carbidopa-Levodopa (AP-CD/LD...
...hours in Tel Aviv and rose NIS1.99 (11%) to NIS20.17 on the exchange. Kevin Lehnbeuter Accordion Pill Cannabidiol/Tetrahydrocannabinol Accordion Pill Carbidopa/Levodopa AP-CBD/THC AP-CDLD carbidopa/levodopa GR Intec...
BioCentury | Nov 8, 2016
Clinical News

Carbidopa/levodopa GR: Ph III amended

...daily vs. Sinemet IR levodopa/carbidopa. Intec Pharma Ltd. (Tel Aviv:NTEC; NASDAQ:NTEC), Jerusalem, Israel Product: Carbidopa/levodopa GR (Accordion Pill Carbidopa/Levodopa...
...parts 2 and 3 scores Status: Phase III amended Milestone: Complete Phase III enrollment (4Q17) Julian Zhu Accordion Pill Carbidopa/Levodopa AP-CDLD carbidopa/levodopa GR Intec...
BioCentury | Apr 11, 2016
Clinical News

Carbidopa/levodopa GR: Phase III started

...in about 460 patients. Intec Pharma Ltd. (Tel Aviv:NTEC; NASDAQ:NTEC), Jerusalem, Israel Product: Carbidopa/levodopa GR ( Accordion Pill Carbidopa/Levodopa...
BioCentury | Aug 4, 2015
Financial News

Intec raises $30.2M in U.S. listing

Intec Pharma Ltd. (Tel Aviv:INTP; NASDAQ:NTEC) held at $6 in its first day of trading on NASDAQ after it raised $30.2 million through the sale of 5 million shares at $6 in a U.S. listing...
Items per page:
1 - 8 of 8